Deutsche Bank
DYN icon

Deutsche Bank’s Dyne Therapeutics DYN Stock Holding History

Deutsche Bank’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.38M Buy
242,392
+21,269
+10% +$395K ﹤0.01% 1333
2026
Q1 		$4.01M Buy
221,123
+25,043
+13% +$432K ﹤0.01% 1416
2025
Q4 		$3.84M Buy
196,080
+70,194
+56% +$1.33M ﹤0.01% 1440
2025
Q3 		$1.59M Sell
125,886
-192,767
-60% -$2.2M ﹤0.01% 1908
2025
Q2 		$3.03M Buy
318,653
+989
+0.3% +$10.9K ﹤0.01% 1473
2025
Q1 		$3.32M Buy
317,664
+246,703
+348% +$3.53M ﹤0.01% 1446
2024
Q4 		$1.67M Buy
70,961
+24,104
+51% +$713K ﹤0.01% 1961
2024
Q3 		$1.68M Buy
46,857
+12,817
+38% +$510K ﹤0.01% 1860
2024
Q2 		$1.2M Buy
34,040
+6,962
+26% +$202K ﹤0.01% 1898
2024
Q1 		$769K Buy
27,078
+6,177
+30% +$140K ﹤0.01% 2147
2023
Q4 		$278K Sell
20,901
-522
-2% -$5.1K ﹤0.01% 2689
2023
Q3 		$192K Buy
21,423
+4,031
+23% +$43.4K ﹤0.01% 2807
2023
Q2 		$196K Sell
17,392
-2,125
-11% -$25.1K ﹤0.01% 2890
2023
Q1 		$225K Buy
19,517
+1,117
+6% +$14.5K ﹤0.01% 2946
2022
Q4 		$213K Buy
18,400
+4,209
+30% +$48.7K ﹤0.01% 2945
2022
Q3 		$180K Sell
14,191
-58
-0.4% -$665 ﹤0.01% 3000
2022
Q2 		$98K Sell
14,249
-2,060
-13% -$14.2K ﹤0.01% 3536
2022
Q1 		$157K Sell
16,309
-1,938
-11% -$16.5K ﹤0.01% 3387
2021
Q4 		$217K Buy
18,247
+974
+6% +$13.7K ﹤0.01% 3348
2021
Q3 		$281K Sell
17,273
-557
-3% -$9.88K ﹤0.01% 3380
2021
Q2 		$375K Buy
17,830
+8,228
+86% +$155K ﹤0.01% 3404
2021
Q1 		$149K Sell
9,602
-2,282
-19% -$44.2K ﹤0.01% 3783
2020
Q4 		$250K Buy
+11,884
New +$235K ﹤0.01% 3340

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Deutsche Bank's DYN Position: Q2 2026 in Review

Deutsche Bank increased its Dyne Therapeutics (DYN) stake by 9.6% in Q2 2026, buying an estimated $395K and bringing the position to 242,392 shares worth $5.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1333.

Deutsche Bank first reported a position in DYN in Q4 2020 and has held it in 23 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Deutsche Bank held 242,392 shares of Dyne Therapeutics worth $5.38M as of Q2 2026.
  • Deutsche Bank bought 21,269 Dyne Therapeutics shares in Q2 2026, an estimated $395K.
  • Dyne Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1333 holding.
  • Deutsche Bank first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.